Kyntra Bio, Inc. (KYNB)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Aug 28, 16:00
7.975
-0.04
(-0.56%)
After-Hours: 20:00
Kyntra Bio Total Return Price : 8.02 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 8.02 |
| August 27, 2026 | 8.00 |
| August 26, 2026 | 8.105 |
| August 25, 2026 | 8.10 |
| August 24, 2026 | 7.98 |
| August 21, 2026 | 7.52 |
| August 20, 2026 | 7.32 |
| August 19, 2026 | 7.15 |
| August 18, 2026 | 7.01 |
| August 17, 2026 | 6.81 |
| August 14, 2026 | 7.05 |
| August 13, 2026 | 7.04 |
| August 12, 2026 | 7.10 |
| August 11, 2026 | 7.07 |
| August 10, 2026 | 6.97 |
| August 07, 2026 | 7.27 |
| August 06, 2026 | 6.980 |
| August 05, 2026 | 6.99 |
| August 04, 2026 | 6.92 |
| August 03, 2026 | 6.76 |
| July 31, 2026 | 6.73 |
| July 30, 2026 | 6.79 |
| July 29, 2026 | 6.78 |
| July 28, 2026 | 6.975 |
| July 27, 2026 | 7.05 |
| Date | Value |
|---|---|
| July 24, 2026 | 7.03 |
| July 23, 2026 | 7.07 |
| July 22, 2026 | 7.215 |
| July 21, 2026 | 7.300 |
| July 20, 2026 | 7.04 |
| July 17, 2026 | 7.23 |
| July 16, 2026 | 7.39 |
| July 15, 2026 | 7.21 |
| July 14, 2026 | 7.32 |
| July 13, 2026 | 7.345 |
| July 10, 2026 | 7.605 |
| July 09, 2026 | 7.32 |
| July 08, 2026 | 7.49 |
| July 07, 2026 | 7.54 |
| July 06, 2026 | 7.25 |
| July 02, 2026 | 7.63 |
| July 01, 2026 | 7.55 |
| June 30, 2026 | 7.55 |
| June 29, 2026 | 7.31 |
| June 26, 2026 | 7.24 |
| June 25, 2026 | 6.94 |
| June 24, 2026 | 6.94 |
| June 23, 2026 | 6.97 |
| June 22, 2026 | 6.88 |
| June 18, 2026 | 6.70 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Vericel Corp. | 40.95 |
| Capricor Therapeutics, Inc. | 9.59 |
| ARS Pharmaceuticals, Inc. | 5.89 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |